“When it comes to soil carbon, there are more questions than answers in terms of whether it’s investable.” and other quotes from the sidelines of the World Agri-Tech and Future Food-Tech conferences in London last week.
The oversubscribed seed round will go towards scaling Jellatech’s proprietary cell-ag process and working towards commercialization.
GRIDX cofounder and CEO Matías Peire on how his company helps scientists build startups that are leading the way for Latin America biotech.
Is it more efficient to make “animal-free” proteins in plants or fermentation tanks? Motif FoodWorks, which currently makes myoglobin via precision fermentation, is now exploring whether corn could also serve as an effective host via a partnership with molecular farming startup IngredientWerks.
Michroma will use the funds to commercialize its line of natural, fungi-derived food colorants before moving on to flavors, fragrances and more.
Powerful data and validated science were just a few of the reasons Middleland Capital led BIOHM’s recent $7.5m funding round.
Innovative Food startups garnered $356 million in 2021; much of that went to Singapore alt-protein companies as well as those in China and India.
Brightseed Bio 01 is a dietary fiber ingredient meant to be incorporated into food and beverage items in order to boost gut health properties.
The insect protein startup plans to operate 10 facilities that farm insects for protein by the end of the decade, starting wtih the US.
Alternative protein technologies like casein and whole-cut “meats” are the first investments from PeakBridge and Edmond de Rothschild Private Equity’s fund.
The San Francisco-based startup will use the funds to bring its first ingredient, which is aimed at improving gut health, to market.
The company is recreating classic refrigerator and pantry staples using novel ingredients and will launch its first product in Spring 2022.
SuperMeat’s co-founder and head of communications talks regulatory approvals, transparency with consumers, and the long-term promise of cultivated meat.
Impossible says its patent on a beef substitute containing synthesized heme – which gives the effect of blood – is being infringed by Motif.
The US-based investment platform’s third installment wants to make food more nutritious, sustainable, and accessible through bioactive elements.
The US company’s e-commerce portal provides a more efficient way to source proteins for novel food ingredients, drug discovery, and more.
The Series B funds will be used to scale up the Irish company’s platform, which aims to unlock additional health benefits for food and beverage products.
It’ll use the Series A capital to hire talent and build an in-house facility to create larger quantities of its ingredients for food manufacturers.
The Pune-based startup aims to grow its presence in North America and Europe, including the establishment of an R&D facility in the Netherlands.
The pair are expanding on their earlier collaboration, which “uncovered 10 times more bioactives than previously known” in the soybean plant.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first